Your browser doesn't support javascript.
Dermatology patients on biologics and certain other systemic therapies should receive a "booster" messenger RNA COVID-19 vaccine dose: A critical appraisal of recent Food and Drug Administration and Advisory Committee on Immunization Practices recommendations.
Waldman, Reid Alexander; Grant-Kels, Jane M.
  • Waldman RA; Dermatology Associates of Glastonbury, Glastonbury, Connecticut. Electronic address: rawaldmanmd@gmail.com.
  • Grant-Kels JM; Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut.
J Am Acad Dermatol ; 85(5): 1113-1116, 2021 Nov.
Article in English | MEDLINE | ID: covidwho-1466528

Full text: Available Collection: International databases Database: MEDLINE Main subject: Skin Diseases / Biological Products / Immunocompromised Host / Practice Guidelines as Topic / COVID-19 Vaccines / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: J Am Acad Dermatol Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Skin Diseases / Biological Products / Immunocompromised Host / Practice Guidelines as Topic / COVID-19 Vaccines / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: J Am Acad Dermatol Year: 2021 Document Type: Article